Intra-operative margin assessment and microenvironment evaluation.
Synthesizing novel cancer drugs that engage new targets
Drug discovery and phenotypically screened translational nanomedicine for anti cancer therapy.
Tissue engineering to define how gradients in biophysical and metabolic properties at the margins of GBM tumors influence GSCs; Identify biophysical and perivascular signals that alter the proliferation and therapeutic resistance.
To develop transgenic pigs as a novel and more human-like model for cancer.
Research and outreach that promotes healthy eating and reduces hunger in families.